Business Standard
Friday, Feb 17, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

Sanofi bags order from US for supplying swine flu vaccine
Press Trust of India / London Sep 22, 2009, 15:24 IST

Sanofi Pasteur, the vaccine division of Sanofi-Aventis Group on Monday said it has received order from the US Department of Health and Human Services (HHS) to supply antigen for 27.3 million doses of Influenza A (H1N1) 2009 monovalent vaccine for swine flu.     

"The new order is for the production of bulk antigen equivalent to 27.3 million doses based on 15 mcg of antigen per dose. Specifications for formulation and filling of this new bulk order will be the subject of a separate order," Sanofi Pasteur said in a statement.     

Till date, Sanofi Pasteur has committed a total of 75.3 million doses of Influenza A(H1N1) 2009 Monovalent Vaccine to the US government, it added.     

Antigen is the basic raw material for producing any vaccines.Sanofi Pasteur had begun the commercial production of the new influenza vaccine in June using the novel virus strain to provide doses for clinical trials and to respond to the initial order from HHS.    

Influenza A (H1N1) 2009 Monovalent Vaccine was licensed by the US health regulator Food and Drug Administration on September 15, 2009. The company has two facilities- one each in US and France for producing the vaccines and it would supply the vaccine to HHS using its US-based production facility.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end higher on firm global cues
- Sena-BJP emerge as largest block in Thane, to retain power
- Nuclear Iran: Anti-India stir gains ground in US
- Tax office seeks review of SC ruling in Vodafone case
- FMC awaits FCRA amendment to decide on pulses trading
  Read Business news in 
- Now property search gets more exciting than ever before!
- High Growth Business Opportunities in Africa - Register to explore
- Medium-sized businesses are the engines of a smarter planet.
- Save over Rs.3000 with IndianOil Citibank Card
- India's No. 1 Property Site. Click here to know more..
- Get 5% cashback on telephone bills with Citi
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Office 365 for professionals and small businesses.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Army to step up vigil in Uttarakhand
- Marico: Stepping into unchartered territory
- MCX IPO to make staff millionaires
- Sonalde Desai: Sons of the soil
- Asian stocks fall as Greek bailout delay dampens mood
 
 More  
BUSINESS STANDARD INDIA 2012
  Now available at Special price
  Rs.395/- Only
  Buy Now
  Now available on the Kindle Store...
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us